Published in Blood Weekly, August 29th, 2002
"There have been several studies on the presence of circulating tumor cells in the peripheral blood of patients with malignant tumors including prostate cancer (PCa) using reverse transcription-PCR (RT-PCR)," according to Noburu Hara and colleagues working at Niigata University in Niigata. "One of the aims of these studies was to obtain high sensitivity that would enable early-stage diagnosis."
PCR blood tests for several prostate-related antigens provided valuable prognostic information cheaply...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Blood Weekly
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.